» Articles » PMID: 25960089

(Anti)mutagenic and Immunomodulatory Properties of Quercetin Glycosides

Overview
Date 2015 May 12
PMID 25960089
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Quercetin-3-O-β-D-glucopyranoside (isoquercitrin) and quercetin-3-O-rutinoside (rutin) are common components of a normal human diet and are increasingly used in food supplements. Here their effect on mutagenesis and immunity is shown.

Results: The in vitro (anti)mutagenic potential was compared with that of quercetin using the Ames test in Salmonella typhimurium His(-) strains TA100, TA98 and TA102. Isoquercitrin only slightly increased the number of revertants, while rutin was totally non-mutagenic. On the other hand, all compounds displayed dose-dependent protective activity against H2O2 - and tert-butyl hydroperoxide-induced oxidative damage to the TA102 strain and at 75 µmol L(-1) inhibited H2O2/Fe(2+)-induced formation of the open circular and linear forms of the DNA plasmid pBSIISK(-). In mice, none of the flavonols (0.86 µmol day(-1), 34 days) induced harmful effects. In immunized animals, all compounds enhanced ex vivo B cell proliferation; quercetin stimulated lymphocyte basal proliferation and increased the number of IgM-producing lymphocytes. Rutin promoted NK cytotoxic activity, supported T cells and enhanced gut epithelium renewal. No effect on IgG-forming cells was found.

Conclusion: Isoquercitrin displayed negligible and rutin no mutagenicity, but both showed significant antimutagenic and DNA-protective effects against oxidative damage. In vivo, they supported the readiness of the immune system for specific humoral immune response.

Citing Articles

Mechanistic prospective and pharmacological attributes of quercetin in attenuation of different types of arthritis.

Bhoi A, Dwivedi S, Singh D, Keshavkant S, Singh M 3 Biotech. 2023; 13(11):362.

PMID: 37840879 PMC: 10570262. DOI: 10.1007/s13205-023-03787-6.


Phytochemical Characteristics and Anti-Inflammatory, Immunoregulatory, and Antioxidant Effects of L.: A Comprehensive Review.

Ghorani V, Saadat S, Khazdair M, Gholamnezhad Z, El-Seedi H, Boskabady M Evid Based Complement Alternat Med. 2023; 2023:2075444.

PMID: 37693918 PMC: 10484659. DOI: 10.1155/2023/2075444.


Enzymatic Hydrolysis of Rutin: Evaluation of Kinetic Parameters and Anti-Proliferative, Mutagenic and Anti-Mutagenic Effects.

Sobreiro M, Della Torre A, de Araujo M, Canella P, de Carvalho J, de Oliveira Carvalho P Life (Basel). 2023; 13(2).

PMID: 36836907 PMC: 9967632. DOI: 10.3390/life13020549.


Potential common mechanism of four Chinese patent medicines recommended by diagnosis and treatment protocol for COVID-19 in medical observation period.

Wang L, Wang Z, Yang Z, Wang X, Yan L, Wu J Front Med (Lausanne). 2022; 9:874611.

PMID: 36388945 PMC: 9643314. DOI: 10.3389/fmed.2022.874611.


Quercetin in the Prevention and Treatment of Coronavirus Infections: A Focus on SARS-CoV-2.

Gasmi A, Mujawdiya P, Lysiuk R, Shanaida M, Peana M, Benahmed A Pharmaceuticals (Basel). 2022; 15(9).

PMID: 36145270 PMC: 9504481. DOI: 10.3390/ph15091049.